Crossmark

Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes

Crossref DOI link: https://doi.org/10.1186/s12933-018-0776-y

Published Online: 2018-10-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mehmood, Sadia

Ye, Chang

Connelly, Philip W.

Hanley, Anthony J.

Zinman, Bernard

Retnakaran, Ravi http://orcid.org/0000-0003-1989-027X
Funding

Funding for this research was provided by:

Canadian Insititutes of Health Research (MOP-84206)

Diabetes Canada (CDA-OG-3-15-4924-RR)

Boehringer Ingelheim (investigator-initiated study)

Sun Life Financial (donation)
License Information

Text and Data Mining valid from 2018-10-09
More Information

Article History

Received: 19 August 2018

Accepted: 4 October 2018

First Online: 9 October 2018

Document is current

Any future updates will be listed below